Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Baxter
Citi
Medtronic
Fish and Richardson
Fuji
Teva
Cerilliant
Moodys

Generated: November 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CARBAMAZEPINE

« Back to Dashboard

Clinical Trials for Carbamazepine

Trial ID Title Status Sponsor Phase Summary
NCT00000191 Carbamazepine Treatment for Cocaine Dependence - 5 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
NCT00000191 Carbamazepine Treatment for Cocaine Dependence - 5 Completed University of Pennsylvania Phase 2 The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
NCT00000217 Pharmacotherapy and Intensive Treatment of Drug Abuse - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Carbamazepine

Condition Name

Condition Name for Carbamazepine
Intervention Trials
Epilepsy 32
Bipolar Disorder 16
Seizures 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Carbamazepine
Intervention Trials
Epilepsy 34
Bipolar Disorder 21
Seizures 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Carbamazepine

Trials by Country

Trials by Country for Carbamazepine
Location Trials
United States 151
Italy 23
Germany 15
Australia 11
France 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Carbamazepine
Location Trials
Maryland 13
New York 10
Texas 9
Pennsylvania 9
North Carolina 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Carbamazepine

Clinical Trial Phase

Clinical Trial Phase for Carbamazepine
Clinical Trial Phase Trials
Phase 4 45
Phase 3 31
Phase 2/Phase 3 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Carbamazepine
Clinical Trial Phase Trials
Completed 89
Recruiting 14
Unknown status 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Carbamazepine

Sponsor Name

Sponsor Name for Carbamazepine
Sponsor Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 10
UCB Pharma 7
GlaxoSmithKline 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Carbamazepine
Sponsor Trials
Other 132
Industry 71
NIH 21
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Colorcon
US Department of Justice
UBS
Cantor Fitzgerald
Johnson and Johnson
Merck
QuintilesIMS
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.